
Twitter Faces Threats from AI and Meta
Motley Fool Money
00:00
Exploring the Growth Potential of Medical Aesthetics with Evolis
This chapter explores the medical aesthetics industry, highlighting Evolis and its flagship product, Juveau, which rivals Botox. It discusses Evolis's unique market position, growth potential, and plans for expansion into dermal fillers by 2028.
Play episode from 15:26
Transcript


